Wall Street brokerages expect that Castlight Health Inc (NYSE:CSLT) will post ($0.04) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Castlight Health’s earnings. The lowest EPS estimate is ($0.05) and the highest is ($0.03). Castlight Health reported earnings of ($0.01) per share in the same quarter last year, which would suggest a negative year over year growth rate of 300%. The firm is expected to report its next earnings report after the market closes on Wednesday, February 21st.
On average, analysts expect that Castlight Health will report full-year earnings of ($0.22) per share for the current year, with EPS estimates ranging from ($0.24) to ($0.21). For the next financial year, analysts forecast that the business will post earnings of ($0.09) per share, with EPS estimates ranging from ($0.12) to ($0.07). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Castlight Health.
CSLT has been the topic of a number of recent research reports. Canaccord Genuity upgraded Castlight Health from a “hold” rating to a “buy” rating in a report on Tuesday, October 10th. BidaskClub upgraded Castlight Health from a “sell” rating to a “hold” rating in a report on Thursday, October 12th. Cantor Fitzgerald reiterated a “hold” rating and issued a $5.00 target price on shares of Castlight Health in a report on Wednesday, October 25th. Chardan Capital lowered their price target on Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th. Finally, Zacks Investment Research raised Castlight Health from a “hold” rating to a “buy” rating and set a $4.50 price target for the company in a research report on Monday, October 30th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. Castlight Health has an average rating of “Hold” and an average target price of $5.11.
Castlight Health (NYSE CSLT) opened at $3.65 on Friday. Castlight Health has a twelve month low of $3.05 and a twelve month high of $4.75. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94. The stock has a market capitalization of $488.14, a price-to-earnings ratio of -7.60 and a beta of 1.57.
In other news, CFO Mangini Siobhan Nolan sold 8,866 shares of the firm’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $3.70, for a total transaction of $32,804.20. Following the completion of the sale, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at approximately $290,675.70. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO John C. Doyle sold 13,686 shares of the firm’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $3.71, for a total value of $50,775.06. Following the sale, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at $458,945.55. The disclosure for this sale can be found here. Insiders sold a total of 22,778 shares of company stock valued at $84,411 over the last three months. 24.38% of the stock is currently owned by insiders.
Several institutional investors have recently made changes to their positions in CSLT. FMR LLC grew its stake in shares of Castlight Health by 49.2% during the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock worth $47,451,000 after acquiring an additional 3,768,009 shares during the period. Cowen Prime Services LLC grew its stake in shares of Castlight Health by 727.5% during the 4th quarter. Cowen Prime Services LLC now owns 1,353,106 shares of the software maker’s stock worth $5,074,000 after acquiring an additional 1,189,586 shares during the period. Vanguard Group Inc. grew its stake in shares of Castlight Health by 36.0% during the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock worth $15,094,000 after acquiring an additional 963,188 shares during the period. GMT Capital Corp bought a new position in shares of Castlight Health during the 3rd quarter worth $3,025,000. Finally, Prudential PLC grew its stake in shares of Castlight Health by 23.5% during the 2nd quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock worth $8,311,000 after acquiring an additional 380,920 shares during the period. 43.40% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This story was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://www.thestockobserver.com/2018/02/05/castlight-health-inc-cslt-expected-to-announce-earnings-of-0-04-per-share.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.